Published by Michele Maatouk on 1st November 2022
(Sharecast News) - Johnson & Johnson said on Tuesday that it has agreed to buy heart recovery specialist Abiomed in a $16.6bn deal.
URL: http://www.digitallook.com/dl/news/story/33075733/...